How to buy Australian Pharmaceutical Industries shares | A$1.03

Australian Pharmaceutical Industries Limited is a medical distribution business based in Australia. Australian Pharmaceutical Industries shares (API) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $1.03 – a decrease of 1.44% over the previous week. Australian Pharmaceutical Industries has a trailing 12-month revenue of around $4.1 billion.

How to buy shares in Australian Pharmaceutical Industries

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Australian Pharmaceutical Industries. Find the share by name or ticker symbol: API. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Australian Pharmaceutical Industries reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $1.03, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Australian Pharmaceutical Industries. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Australian Pharmaceutical Industries's share price?

Since the stock market crash in March caused by coronavirus, Australian Pharmaceutical Industries's share price has had significant negative movement.

Its last market close was $1.03, which is 19.53% down on its pre-crash value of $1.28 and 2.49% up on the lowest point reached during the March crash when the shares fell as low as $1.005.

If you had bought $1,000 worth of Australian Pharmaceutical Industries shares at the start of February 2020, those shares would have been worth $845.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $795.37.

Australian Pharmaceutical Industries share price

Use our graph to track the performance of API stocks over time.

Australian Pharmaceutical Industries shares at a glance

• Key figures

Information last updated 2020-09-20.

Latest market close	AUDA$1.03
52-week range	AUDA$1.005 - AUDA$1.52
50-day moving average	AUDA$1.088
200-day moving average	AUDA$1.1289
Target price	AUDA$1.71
PE ratio	9.6226
Dividend yield	AUDA$0.08 (6.87%)
Earnings per share (TTM)	AUDA$0.106

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Australian Pharmaceutical Industries stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Australian Pharmaceutical Industries Limited by TradingView

Australian Pharmaceutical Industries price performance over time

Historical closes compared with the last close of A$1.03

1 week (2020-09-11)	-1.44%
1 month (2020-08-20)	-7.21%
3 months (2020-06-19)	-10.04%
6 months (2020-03-20)	-8.85%

1 year (2019-09-20)	-23.99%
2 years (2018-09-20)	-46.77%
3 years (2017-09-20)	-29.69%
5 years (2015-09-18)	-35.63%

Is Australian Pharmaceutical Industries under- or over-valued?

Valuing Australian Pharmaceutical Industries stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Australian Pharmaceutical Industries's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Australian Pharmaceutical Industries's P/E ratio

Australian Pharmaceutical Industries's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Australian Pharmaceutical Industries shares trade at around 10x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Australian Pharmaceutical Industries's PEG ratio

Australian Pharmaceutical Industries's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Australian Pharmaceutical Industries's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Australian Pharmaceutical Industries's EBITDA

Australian Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $100.2 million (£0.0 million).

The EBITDA is a measure of a Australian Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.

Australian Pharmaceutical Industries financials

Revenue TTM	$4.1 billion
Operating margin TTM	2.02%
Gross profit TTM	$518.3 million
Return on assets TTM	3.19%
Return on equity TTM	10.62%
Profit margin	1.29%
Book value	1.025
Market capitalisation	$502.5 million

TTM: trailing 12 months

Australian Pharmaceutical Industries share dividends

Dividend payout ratio: 73.11% of net profits

Recently Australian Pharmaceutical Industries has paid out, on average, around 73.11% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.87% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Australian Pharmaceutical Industries shareholders could enjoy a 6.87% return on their shares, in the form of dividend payments. In Australian Pharmaceutical Industries's case, that would currently equate to about A$0.08 per share.

Australian Pharmaceutical Industries's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 12 November 2019 (the "ex-dividend date").

Have Australian Pharmaceutical Industries's shares ever split?

Australian Pharmaceutical Industries's shares were split on 22 October 2009.

Australian Pharmaceutical Industries share price volatility

Over the last 12 months, Australian Pharmaceutical Industries's shares have ranged in value from as little as $1.005 up to $1.52. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Australian Pharmaceutical Industries's is 0.3283. This would suggest that Australian Pharmaceutical Industries's shares are less volatile than average (for this exchange).

Australian Pharmaceutical Industries overview

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. The company also retails health and beauty products to consumers; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and procedures. In addition, its services include wholesale product delivery, retail services, marketing programs, and business advisory services. The company markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as through 488 Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.

Frequently asked questions

• What percentage of Australian Pharmaceutical Industries is owned by insiders or institutions?

  Currently 1.827% of Australian Pharmaceutical Industries shares are held by insiders and 40.444% by institutions.

• When does the fiscal year end for Australian Pharmaceutical Industries?

  Australian Pharmaceutical Industries's fiscal year ends in August.

• Where is Australian Pharmaceutical Industries based?

  Australian Pharmaceutical Industries's address is: 250 Camberwell Road, Camberwell, VIC, Australia, 3124

• What is Australian Pharmaceutical Industries's ISIN number?

  Australian Pharmaceutical Industries's international securities identification number is: AU000000API4